Javelin Pharmaceuticals (JAV +61.2%) delivers a notice of intent to terminate its merger...


Javelin Pharmaceuticals (JAV +61.2%) delivers a notice of intent to terminate its merger agreement with Myriad Pharmaceuticals (MYRX +7.1%) after receiving a buyout offer from Hospira (HSP -0.2%) for $2.20 per share. (PR)

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs